AGP Picks
View all

New Jersey Health Reporter
Provided by AGP

New Jersey Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on April 9, 2026

Alliance Orthopedics and Alliance Performance To Host Grand Opening Event in Fair Lawn
Apr. 9, 2026

Alliance Orthopedics and Alliance Performance To Host Grand Opening Event in Fair Lawn

Indeterminate EIN Presswire
HPS Flooring Announces Specialized Epoxy Solutions Engineered for High-Demand Mechanical Rooms
Apr. 9, 2026

HPS Flooring Announces Specialized Epoxy Solutions Engineered for High-Demand Mechanical Rooms

Indeterminate EIN Presswire
Tiger Tail Brings AI Implementation to Mid-Size Businesses, Helping Companies Automate Operations and Accelerate Growth
Apr. 9, 2026

Tiger Tail Brings AI Implementation to Mid-Size Businesses, Helping Companies Automate Operations and Accelerate Growth

Indeterminate EIN Presswire
Besler Holdings Announces IT Leader Ramey Burke Joins Team
Apr. 9, 2026

Besler Holdings Announces IT Leader Ramey Burke Joins Team

Indeterminate EIN Presswire
Palisades Therapeutics’ PT150 Emerges as First‑in‑Class 'Metabolic Setpoint Modifier' to Lock In GLP‑1 Weight Loss
Apr. 9, 2026

Palisades Therapeutics’ PT150 Emerges as First‑in‑Class 'Metabolic Setpoint Modifier' to Lock In GLP‑1 Weight Loss

Indeterminate EIN Presswire
Silver Defender Announces Historical Breakthrough in Surface Intelligence
Apr. 9, 2026

Silver Defender Announces Historical Breakthrough in Surface Intelligence

Indeterminate EIN Presswire
Vita Smart Cup Massager Claims Evaluated: 2026 Report on Suction Therapy, Red Light Technology, and What Consumers Should Know Before Buying
Apr. 9, 2026

Vita Smart Cup Massager Claims Evaluated: 2026 Report on Suction Therapy, Red Light Technology, and What Consumers Should Know Before Buying

Indeterminate GlobeNewswire
FDA Accepts NDA for TLX101-Px (Pixclara®)
Apr. 9, 2026

FDA Accepts NDA for TLX101-Px (Pixclara®)

Indeterminate GlobeNewswire
Extendicare Announces $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes
Apr. 9, 2026

Extendicare Announces $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes

Indeterminate GlobeNewswire
Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference
Apr. 9, 2026

Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
Dental Care of Stamford Challenges the Myths Holding Stamford Residents Back from the Smile They Want
Apr. 9, 2026

Dental Care of Stamford Challenges the Myths Holding Stamford Residents Back from the Smile They Want

Indeterminate GlobeNewswire
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
Apr. 9, 2026

Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program

Indeterminate GlobeNewswire
eHealth Exchange Demonstrates Real-World Patient Access Capability, Advancing CMS-Aligned Network Goals
Apr. 9, 2026

eHealth Exchange Demonstrates Real-World Patient Access Capability, Advancing CMS-Aligned Network Goals

Indeterminate GlobeNewswire
Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
Apr. 9, 2026

Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN

Indeterminate GlobeNewswire
Sobi reçoit l’autorisation par Santé Canada pour EMPAVELIMD (pegcétacoplan) dans le traitement de la GC3 et de la GNMP-CI primitive.
Apr. 9, 2026

Sobi reçoit l’autorisation par Santé Canada pour EMPAVELIMD (pegcétacoplan) dans le traitement de la GC3 et de la GNMP-CI primitive.

Indeterminate GlobeNewswire
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
Apr. 9, 2026

Certara to Report First Quarter 2026 Financial Results on May 11th, 2026

Indeterminate GlobeNewswire
Solana Company (NASDAQ: HSDT) Appoints Madelene Gani as Chief Operating Officer and Deputy CFO to Lead Next Phase of Growth
Apr. 9, 2026

Solana Company (NASDAQ: HSDT) Appoints Madelene Gani as Chief Operating Officer and Deputy CFO to Lead Next Phase of Growth

Indeterminate GlobeNewswire
LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference
Apr. 9, 2026

LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
Apr. 9, 2026

PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026

Indeterminate GlobeNewswire
Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting
Apr. 9, 2026

Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

New Jersey Health Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.